Gland Pharma Ltd (GLAND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003443, "name": "Gland Pharma", "stock_name": "Gland Pharma", "full_name": "Gland Pharma Ltd", "name_url": "stocks-analysis/gland-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,713.00", "chg": 44.55, "chgp": "2.67%", "dir": 1, "prev_price": "1,668.45", "mcapval": "27,877.00 Cr", "mcap": "Small Cap", "scripcode": 543245, "symbol": "GLAND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE068V01023", "curr_date": "Mar 25", "curr_time": "", "bse_nse_vol": "62.93 k", "exc_status": "Active", "traded_date": "Mar 25, 2026", "traded_date_str": "2026 03 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3909244", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_technicaldot_3909244.png", "date": "2026-03-24 08:04:44", "description": "Gland Pharma Ltd has experienced a subtle yet significant shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. This change is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and other momentum oscillators, reflecting a nuanced market sentiment for the pharmaceutical and biotechnology company." }, { "title": "Gland Pharma's Technical Turbulence: 3.71% Weekly Decline Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharmas-technical-turbulence-371-weekly-decline-amid-mixed-signals-3905137", "imagepath": "", "date": "2026-03-21 12:03:17", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Mar:</strong> Downgrade to Sell amid technical weakness and valuation concerns</p>\n <p><strong>17 Mar:</strong> Technical momentum shifts to mildly bearish with mixed signals</p>\n <p><strong>19 Mar:</strong> Upgrade to Hold following technical improvements</p>\n <p><strong>20 Mar:</strong> Bearish momentum returns with price decline of 4.11%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,627.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div ..." }, { "title": "Gland Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-faces-bearish-momentum-amid-technical-downgrade-3902338", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_technicaldot_3902338.png", "date": "2026-03-20 08:03:53", "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined sharply in recent sessions, reflecting a deteriorating outlook amid mixed signals from various technical parameters and a recent upgrade in its Mojo Grade from Sell to Hold." }, { "title": "Gland Pharma Ltd Upgraded to Hold by MarketsMOJO on Technical Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-upgraded-to-hold-by-marketsmojo-on-technical-improvements-3899853", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_mojoScore_3899853.png", "date": "2026-03-19 08:16:06", "description": "Gland Pharma Ltd has seen its investment rating upgraded from Sell to Hold as of 18 Mar 2026, reflecting a nuanced improvement in its technical indicators, financial performance, valuation metrics, and overall quality assessment. This shift comes amid a backdrop of mixed long-term growth but recent positive quarterly results and stabilising technical trends, signalling a cautious but more optimistic outlook for investors in this small-cap pharmaceutical player." }, { "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3895750", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_technicaldot_3895750.png", "date": "2026-03-17 08:03:59", "description": "Gland Pharma Ltd has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators amid a challenging market environment for the pharmaceuticals and biotechnology sector." }, { "title": "Gland Pharma Downgraded to Sell Amid Technical Weakness and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3892868", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_mojoScore_3892868.png", "date": "2026-03-16 08:15:04", "description": "Gland Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 13 March 2026. The downgrade reflects a combination of deteriorating technical indicators, expensive valuation metrics, subdued long-term financial growth, and mixed quality assessments, signalling caution for investors despite recent positive quarterly results." }, { "title": "Gland Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-faces-bearish-momentum-amid-technical-downgrade-3892789", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_technicaldot_3892789.png", "date": "2026-03-16 08:03:02", "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from Hold to Sell by MarketsMOJO, coupled with a 1.96% decline in price, reflects growing investor caution amid mixed technical signals and underwhelming short-term returns compared to the broader Sensex." }, { "title": "Gland Pharma Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-hold-3888303", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_mojoScore_3888303.png", "date": "2026-03-13 10:10:43", "description": "Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Gland Pharma Declines 8.45%: Four Key Factors Shaping This Week’s Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-declines-845-four-key-factors-shaping-this-weeks-performance-3878139", "imagepath": "", "date": "2026-03-07 12:04:54", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Significant gap down opening amid market concerns</p>\n <p><strong>4 Mar:</strong> Technical momentum shifts with mixed indicator signals</p>\n <p><strong>4 Mar:</strong> Valuation shift signals improved price attractiveness</p>\n <p><strong>5 Mar:</strong> Technical momentum turns mildly bearish amid volatility</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,823.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..." } ], "total": 363, "sid": "1003443", "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "18-Mar-2026", "details": "Schedule of Investor Meet", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "13-Mar-2026", "details": "Schedule of Investor Meet Intimation", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "11-Mar-2026", "details": "Schedule of Investor Meet", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Gland Pharma Ltd has declared <strong>1800%</strong> dividend, ex-date: 14 Aug 25", "dt": "2025-08-14", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

16 Mar: Downgrade to Sell amid technical weakness and valuation concerns

17 Mar: Technical momentum shifts to mildly bearish with mixed signals

19 Mar: Upgrade to Hold following technical improvements

20 Mar: Bearish momentum returns with price decline of 4.11%

Week Open

Rs.1,627.75

Week Close

Read full news article

Gland Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-03-20 08:03:53

Gland Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined sharply in recent sessions, reflecting a deteriorating outlook amid mixed signals from various technical parameters and a recent upgrade in its Mojo Grade from Sell to Hold.

Read full news article

Gland Pharma Ltd Upgraded to Hold by MarketsMOJO on Technical Improvements

2026-03-19 08:16:06

Gland Pharma Ltd has seen its investment rating upgraded from Sell to Hold as of 18 Mar 2026, reflecting a nuanced improvement in its technical indicators, financial performance, valuation metrics, and overall quality assessment. This shift comes amid a backdrop of mixed long-term growth but recent positive quarterly results and stabilising technical trends, signalling a cautious but more optimistic outlook for investors in this small-cap pharmaceutical player.

Read full news article

Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-03-17 08:03:59

Gland Pharma Ltd has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators amid a challenging market environment for the pharmaceuticals and biotechnology sector.

Read full news article

Gland Pharma Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-03-16 08:15:04

Gland Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 13 March 2026. The downgrade reflects a combination of deteriorating technical indicators, expensive valuation metrics, subdued long-term financial growth, and mixed quality assessments, signalling caution for investors despite recent positive quarterly results.

Read full news article

Gland Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-03-16 08:03:02

Gland Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from Hold to Sell by MarketsMOJO, coupled with a 1.96% decline in price, reflects growing investor caution amid mixed technical signals and underwhelming short-term returns compared to the broader Sensex.

Read full news article

Gland Pharma Ltd is Rated Hold

2026-03-13 10:10:43

Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.